| [1] |
黎鳌，杨宗城. 黎鳌烧伤学[M]. 上海：上海科学技术出版社，2001: 67-80.
|
| [2] |
张成，彭源，罗小强，等. 3067例住院烧伤患儿流行病学调查及其感染的病原学特征分析[J]. 中华烧伤杂志，2021, 37(6): 538-545.
|
| [3] |
Tchakal-Mesbahi A, Abdouni MA, Metref M. Prevalence Of Multidrug-Resistant Bacteria Isolated From Burn Wounds In Algeria[J]. Ann Burns Fire Disasters, 2021, 34(2): 150-156.
|
| [4] |
Harding CM, Hennon SW, Feldman MF. Uncovering the mechanisms of Acinetobacter baumannii virulence[J]. Nat Rev Microbiol, 2018, 16(2): 91-102.
|
| [5] |
Kaushik V, Tiwari M, Joshi R, et al. Therapeutic strategies against potential antibiofilm targets of multidrug-resistantAcinetobacter baumannii[J]. J Cell Physiol, 2022, 237(4): 2045-2063.
|
| [6] |
王丽英，王凌峰. 鲍曼不动杆菌生物膜耐药机制及防治进展[J/CD]. 中华临床医师杂志(电子版), 2014, 8(5): 970-974.
|
| [7] |
刘薇，程翔，梁玉龙，等. 不同烧伤面积患者创面感染病原菌分布及其耐药性[J]. 中国感染控制杂志，2022, 21(1): 30-36.
|
| [8] |
徐优耀，张桂华，刘莹. 烧伤住院患者感染病原菌的分布及耐药性分析[J]. 中国冶金工业医学杂志，2022, 39(2): 217-218.
|
| [9] |
宋均辉，夏正国，黄庆，等. 烧伤病房内小儿烧伤创面感染病原菌调查及抗生素敏感性分析[J/CD]. 中华损伤与修复杂志(电子版), 2019, 14(1): 46-51.
|
| [10] |
丁华荣，胡加平，李德绘，等. 烧伤整形外科1963株细菌及其耐药情况分析[J]. 广西医科大学学报，2019, 36(1): 102-106.
|
| [11] |
常璠，纪荣祖，朱宏伟，等. 2014-2018年某院烧伤患者感染细菌分布及耐药性分析[J]. 中外医学研究，2019, 17(29): 69-72.
|
| [12] |
De Oliveira DMP, Forde BM, Kidd TJ, et al. Antimicrobial Resistance in ESKAPE Pathogens[J]. Clin Microbiol Rev, 2020, 33(3): e00181-119.
|
| [13] |
Pulingam T, Parumasivam T, Gazzali AM, et al. Antimicrobial resistance: Prevalence, economic burden, mechanisms of resistance and strategies to overcome[J]. Eur J Pharm Sci, 2022, 170: 106103.
|
| [14] |
刘秋萍，徐凌. 鲍曼不动杆菌耐药机制的研究进展[J]. 中国抗生素杂志，2018, 43(10): 1179-1187.
|
| [15] |
Vrancianu CO, Gheorghe I, Czobor IB, et al. Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii[J]. Microorganisms, 2020, 8(6)：935.
|
| [16] |
Sloczynska A, Wand ME, Tyski S, et al. Analysis of blaCHDL Genes and Insertion Sequences Related to Carbapenem Resistance in Acinetobacter baumannii Clinical Strains Isolated in Warsaw, Poland[J]. Int J Mol Sci, 2021, 22(5): 2486.
|
| [17] |
Hawkey J, Ascher DB, Judd LM, et al. Evolution of carbapenem resistance in Acinetobacter baumannii during a prolonged infection[J]. Microb Genom, 2018, 4(3): e000165.
|
| [18] |
Zhong X, Wu X, Schweppe DK, et al. In Vivo Cross-Linking MS Reveals Conservation in OmpA Linkage to Different Classes of β-Lactamase Enzymes[J]. J Am Soc Mass Spectrom, 2020, 31(2): 190-195.
|
| [19] |
Zhu LJ, Chen XY, Hou PF. Mutation of CarO participates in drug resistance in imipenem-resistantAcinetobacter baumannii[J]. J Clin Lab Anal, 2019, 33(8): e22976.
|
| [20] |
Yaghi J, Fattouh N, Akkawi C, et al. Unusually High Prevalence of Cosecretion of Ambler Class A and B Carbapenemases and Nonenzymatic Mechanisms in Multidrug-Resistant Clinical Isolates ofPseudomonas aeruginosa in Lebanon[J]. Microb Drug Resist, 2020, 26(2): 150-159.
|
| [21] |
Leus IV, Weeks JW, Bonifay V, et al. Substrate Specificities and Efflux Efficiencies of RND Efflux Pumps of Acinetobacter baumannii[J]. J Bacteriol, 2018, 200(13): e00049-18.
|
| [22] |
Garneau-Tsodikova S, Labby KJ. Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives[J]. Medchemcomm, 2016, 7(1): 11-27.
|
| [23] |
Kishk R, Soliman N, Nemr N, et al. Prevalence of Aminoglycoside Resistance and Aminoglycoside Modifying Enzymes in Acinetobacter baumannii Among Intensive Care Unit Patients, Ismailia, Egypt[J]. Infect Drug Resist, 2021, 14: 143-150.
|
| [24] |
Xu C, Bilya SR, Xu W. adeABC efflux gene in Acinetobacter baumannii[J]. New Microbes New Infect, 2019, 30: 100549.
|
| [25] |
Lee CR, Lee JH, Park M, et al. Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options[J]. Front Cell Infect Microbiol, 2017, 7: 55.
|
| [26] |
Beabout K, Hammerstrom TG, Perez AM, et al. The ribosomal S10 protein is a general target for decreased tigecycline susceptibility[J]. Antimicrob Agents Chemother, 2015, 59(9): 5561-5566.
|
| [27] |
Hua X, He J, Wang J, et al. Novel tigecycline resistance mechanisms in Acinetobacter baumannii mediated by mutations in adeS, rpoB and rrf[J]. Emerg Microbes Infect, 2021, 10(1): 1404-1417.
|
| [28] |
Zhang J, Xie J, Li H, et al. Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients[J]. Microbiol Spectr, 2022, 10(1): e159321.
|
| [29] |
Lucassen K, Muller C, Wille J, et al. Prevalence of RND efflux pump regulator variants associated with tigecycline resistance in carbapenem-resistant Acinetobacter baumannii from a worldwide survey[J]. J Antimicrob Chemother, 2021, 76(7): 1724-1730.
|
| [30] |
Trebosc V, Gartenmann S, Tötzl M, et al. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates[J]. mBio, 2019, 10(4): e01083-19.
|
| [31] |
Sun B, Liu H, Jiang Y, et al. New Mutations Involved in Colistin Resistance in Acinetobacter baumannii[J]. mSphere, 2020, 5(2): e00895-19.
|
| [32] |
Hussein NH, Al-Kadmy IMS, Taha BM, et al. Mobilized colistin resistance (mcr) genes from 1 to 10: a comprehensive review[J]. Mol Biol Rep, 2021, 48(3): 2897-2907.
|
| [33] |
Thi Khanh Nhu N, Riordan DW, Do Hoang Nhu T, et al. The induction and identification of novel Colistin resistance mutations in Acinetobacter baumannii and their implications[J]. Sci Rep, 2016, 6: 28291.
|
| [34] |
Lin MF, Lin YY, Lan CY. Contribution of EmrAB efflux pumps to colistin resistance in Acinetobacter baumannii[J]. J Microbiol, 2017, 55(2): 130-136.
|
| [35] |
D′Souza R, Pinto NA, Phuong NL, et al. Phenotypic and Genotypic Characterization of Acinetobacter spp. Panel Strains: A Cornerstone to Facilitate Antimicrobial Development[J]. Front Microbiol, 2019, 10: 559.
|
| [36] |
Nogbou ND, Nkawane GM, Ntshane K, et al. Efflux Pump Activity and Mutations Driving Multidrug Resistance in Acinetobacter baumannii at a Tertiary Hospital in Pretoria, South Africa[J]. Int J Microbiol, 2021, 2021: 9923816.
|
| [37] |
Zaki MES, Abou EN, Mofreh M. Molecular Study of Quinolone Resistance Determining Regions of gyrA Gene and parC Genes in Clinical Isolates of Acintobacter baumannii Resistant to Fluoroquinolone[J]. Open Microbiol J, 2018, 12: 116-122.
|
| [38] |
Mohammed MA, Salim MTA, Anwer BE, et al. Impact of target site mutations and plasmid associated resistance genes acquisition on resistance of Acinetobacter baumannii to fluoroquinolones[J]. Sci Rep, 2021, 11(1): 20136.
|
| [39] |
Roy S, Chatterjee S, Bhattacharjee A, et al. Overexpression of Efflux Pumps, Mutations in the Pumps' Regulators, Chromosomal Mutations, and AAC(6′)-Ib-cr Are Associated With Fluoroquinolone Resistance in Diverse Sequence Types of Neonatal Septicaemic Acinetobacter baumannii: A 7-Year Single Center Study[J]. Front Microbiol, 2021, 12: 602724.
|
| [40] |
Okada U, Yamashita E, Neuberger A, et al. Crystal structure of tripartite-type ABC transporter MacB from Acinetobacter baumannii[J]. Nat Commun, 2017, 8(1): 1336.
|
| [41] |
Martinez-Trejo A, Ruiz-Ruiz JM, Gonzalez-Avila LU, et al. Evasion of Antimicrobial Activity in Acinetobacter baumannii by Target Site Modifications: An Effective Resistance Mechanism[J]. Int J Mol Sci, 2022, 23(12): 6582.
|
| [42] |
Girija ASS, Vijayashree Priyadharsini J, Paramasivam A. Plasmid-encoded resistance to trimethoprim/sulfamethoxazole mediated by dfrA1, dfrA5, sul1 and sul2 among Acinetobacter baumannii isolated from urine samples of patients with severe urinary tract infection[J]. J Glob Antimicrob Resist, 2019, 17: 145-146.
|